Assistant professor in our department, @DominicMoonMD, presenting his work, “HYHOPE: A Phase I Study of De-Intensified Hypofractionated Radiation Therapy for Human Papillomavirus-Associated Oropharynx Cancer.” #ASTRO24
Thrilled to see our INRT-AIR trial out in press!
In this phase II study, we **eliminated** elective nodal irradiation for patients with HSNCC treated with definitive RT/CRT.
aacrjournals.org/clincancerr…
Very happy for @DominicMoonMD to see his HYPORT study out in @IJROBP.
@UTSW_RadOnc phase I trial of hypofractionated adjuvant RT for resected HNSCC: 3 weeks of treatment!
46.5 Gy/15 fx then 44.4 Gy/12 fx. 6 pts/cohort.
redjournal.org/article/S0360…